Concepedia

Joseph-Leon Aumann

JA

6

Publications

311

Citations

6

H-Index

1993

Active since

Affiliations

Boehringer Ingelheim (United States)(Current)

Boehringer Ingelheim (Canada)

Ghent University Hospital

Boehringer Ingelheim (Germany)

Joseph-Leon Aumann is an author at Boehringer Ingelheim (United States) specializing in pharmacotherapy, pulmonary disease, and atherosclerosis.

Top concepts

Publications per year

1993–2019

6

Publications

6

Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening

D.S. Postma, C. Sevette, Yan Martinat et al. · European Respiratory Journal · 2001 · 130 citations · Full text

Relationship between lung tissue and blood plasma concentrations of inhaled budesonide

Jules M.M. van den Bosch, C. J. J. Westermann, Joseph-Leon Aumann et al. · Biopharmaceutics & Drug Disposition · 1993 · 90 citations

Dual bronchodilation with tiotropium/olodaterol further reduces activity-related breathlessness<i>versus</i>tiotropium alone in COPD

François Maltais, Joseph-Leon Aumann, Anne‐Marie Kirsten et al. · European Respiratory Journal · 2019 · 34 citations · Full text

The 24 Hour Lung Function Time Profile of Olodaterol Once Daily Versus Placebo and Tiotropium in Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Joseph-Leon Aumann · Journal of Pulmonary & Respiratory Medicine · 2014 · 28 citations · Full text

A randomised, double-blind, four-way, crossover trial comparing the 24-h FEV1 profile for once-daily versus twice-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with chronic obstructive pulmonary disease

Guy Joos, Joseph-Leon Aumann, Carl Coeck et al. · Respiratory Medicine · 2015 · 16 citations · Full text

Rows per page

1–5 of 6